Drawing for CORREGENE

USPTO serial 79339878

CORREGENE

Reviewed by CopyMark Law Group

Reg. 7129005Status 700Registered
Filing date
Status date
Registration date
Aug 8, 2023
Examiner
GARCIA, CLAUDIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CORREGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert J. Kenney

Robert J. Kenney Willcox & Savage, P.C.8201 Greensboro Drive, Suite 1001Attn.: IP AdministratorMcLean, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005Cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; veterinary preparations for the prevention and treatment of intestinal bacteria, colibacillosis, salmonellosis, pasteurella, brucellosis, foot-and-mouth disease, tuberculosis, plague, infectious diseases, influenza, immune related diseases and nutrient deficiency related diseases; stem cells for veterinary purposes; preparations for destroying noxious animalsACTIVE—
042product quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; medical and scientific research, namely, conducting clinical trials for others; genomic structure and function analysis; genetic testing for scientific research; the testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 11, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 11, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 11, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 9, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 9, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 8, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 8, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 8, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 23, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 3, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 15, 2022RFNTREFUSAL PROCESSED BY IB—
Oct 21, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 21, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2022DOCKASSIGNED TO EXAMINER—
May 10, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 5, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance